Disclosure Of Entity's Operating Segments [Text Block]

GenSight Biologics S.A. - Filing #5982864

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
Disclosure of entity's operating segments [text block]
3
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue
1 500 EUR
1,267,000 EUR
Tax expense (income)
21,000 EUR
0 EUR
Profit (loss)
14 001 EUR
14 001 EUR
26,220,000 EUR
26,220,000 EUR
Assets
10 756 EUR
9,132,000 EUR
Cash flows from (used in) operating activities
12 937 EUR
24,663,000 EUR
Cash flows from (used in) investing activities
17,000 EUR
209,000 EUR
Cash flows from (used in) financing activities
13 542 EUR
15,859,000 EUR
Disclosure of products and services [text block]
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]
Disclosure of major customers [abstract]
Disclosure of major customers [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.